{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T02:35:56Z","timestamp":1782873356529,"version":"3.54.5"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Pulmonary embolism (PE) is a serious condition that is frequently encountered in clinical practice. It has been demonstrated that the body\u2019s physiological responses to platelet activation can lead to significant complications, including pulmonary hypertension, bronchoconstriction, and right heart failure. Albumin is recognized as a composite indicator of acute-phase reactant proteins, which have osmotic and anti-inflammatory properties, as well as nutrient and metabolic imbalance. Albumin demonstrates independent prognostic value in a variety of diseases. The platelet-to-albumin ratio (PAR) has emerged as a reliable predictor of mortality and complications based on systemic inflammation in a number of diseases. However, studies on the relationship between PAR and adverse outcomes in critically ill patients with pulmonary embolism are limited. Thus, this study aimed to investigate whether PAR could be a useful indicator for assessing pulmonary embolism outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The clinical data of 1163 patients with critical pulmonary embolisms were extracted from the MIMIC-IV (version 2.2) database. The study population was categorized into four groups according to PAR quartiles. The primary regression was 28-day ICU mortality, while the secondary regressions were 7-d and 14-d ICU mortality. Restricted cubic splines, Cox proportional hazards regression, and Kaplan-Meier curves were used to explore the relationship between PAR and adverse outcomes. We assessed the predictive power of PAR using the Boruta algorithm and built predictive models using machine learning algorithms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Data from 1163 patients diagnosed with pulmonary embolism were analyzed. Lower PAR was significantly associated with an increased risk of 7-d (\n                      <jats:italic>p<\/jats:italic>\n                      &amp;lt; 0.001), 14-d (\n                      <jats:italic>p<\/jats:italic>\n                      &amp;lt; 0.001), and 28-d (\n                      <jats:italic>p<\/jats:italic>\n                      &amp;lt; 0.005) ICU mortality compared with higher PAR. The restricted cubic spline curve revealed an \u201cL-shaped\u201d relationship between PAR and survival, suggesting that an increase in PAR is linked to a reduced risk of adverse events. Patients with lower PAR had a higher risk of death within 7, 14, and 28 days in the ICU compared to those with higher PAR (\n                      <jats:italic>p<\/jats:italic>\n                      &amp;lt; 0.05). Boruta feature selection showed PAR had a higher Z score, and the model built using the Conditional Inference Trees algorithm had the best performance (AUC = 0.623).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>PAR showed an \u201cL\u201d-shaped relationship with all-cause mortality at 7, 14, and 28 days in critically ill patients. Low PAR was significantly associated with an increased risk of adverse events, suggesting that PAR may be a predictor of adverse outcomes in patients with pulmonary embolisms.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2025.1680205","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T05:28:05Z","timestamp":1761283685000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Association between the platelet-to-albumin ratio and 28-day all-cause mortality in critically ill patients with Pulmonary embolism: a retrospective cohort study and predictive model establishment based on machine learning"],"prefix":"10.3389","volume":"12","author":[{"given":"Danyang","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuhong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"18028","DOI":"10.1038\/nrdp.2018.28","article-title":"Pulmonary embolism.","volume":"4","author":"Marshall","year":"2018","journal-title":"Nat Rev Dis Primers."},{"key":"B2","doi-asserted-by":"publisher","first-page":"101258","DOI":"10.1016\/j.lanwpc.2024.101258","article-title":"Epidemiology of pulmonary embolism in China, 2021: a nationwide hospital-based study.","volume":"54","author":"Zhen","year":"2025","journal-title":"Lancet Reg Health West Pac."},{"key":"B3","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1160\/TH12-09-0658","article-title":"Prevalence of thrombocytosis in critically ill patients and its association with symptomatic acute pulmonary embolism. A multicentre registry study.","volume":"109","author":"Ho","year":"2013","journal-title":"Thromb Haemost."},{"key":"B4","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1182\/blood.2023020872","article-title":"PF4 activates the c-Mpl-Jak2 pathway in platelets.","volume":"143","author":"Buka","year":"2024","journal-title":"Blood."},{"key":"B5","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3390\/medicina56010026","article-title":"Association of serum albumin and severity of pulmonary embolism.","volume":"56","author":"Omar","year":"2020","journal-title":"Medicina."},{"key":"B6","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12872-023-03097-y","article-title":"The relationship between leukocyte to albumin ratio and atrial fibrillation severity.","volume":"23","author":"Lessomo","year":"2023","journal-title":"BMC Cardiovasc Disord."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1002\/hep.20720","article-title":"Albumin: biochemical properties and therapeutic potential.","volume":"41","author":"Quinlan","year":"2005","journal-title":"Hepatology."},{"key":"B8","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1186\/s40001-024-02235-2","article-title":"High platelet-to-albumin ratio is associated with 30-day mortality in critically ill patients.","volume":"29","author":"Liu","year":"2024","journal-title":"Eur J Med Res."},{"key":"B9","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1186\/s12871-023-02137-6","article-title":"Role of platelet to albumin ratio for predicting persistent acute kidney injury in patients admitted to the intensive care unit.","volume":"23","author":"Zhai","year":"2023","journal-title":"BMC Anesthesiol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"842362","DOI":"10.3389\/fimmu.2022.842362","article-title":"Platelet-to-albumin ratio: a novel IgA nephropathy prognosis predictor.","volume":"13","author":"Tan","year":"2022","journal-title":"Front Immunol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"987","DOI":"10.21873\/anticanres.12313","article-title":"Preoperative platelet to albumin ratio predicts outcome of patients with cholangiocarcinoma.","volume":"38","author":"Saito","year":"2018","journal-title":"Anticancer Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1186\/s12885-024-12499-w","article-title":"Prognostic significance of platelet-to-albumin ratio in patients with nasopharyngeal carcinoma receiving concurrent chemoradiotherapy: a retrospective study of 858 cases.","volume":"24","author":"Hua","year":"2024","journal-title":"BMC Cancer."},{"key":"B13","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1186\/s12882-024-03792-8","article-title":"Platelet-to-albumin ratio: a potential biomarker for predicting all-cause and cardiovascular mortality in patients undergoing peritoneal dialysis.","volume":"25","author":"Ma","year":"2024","journal-title":"BMC Nephrol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1097\/MCA.0000000000001445","article-title":"Platelet-to-albumin ratio is an independent predictor for ventricular aneurysm formation in ST segment elevation myocardial infarction.","volume":"36","author":"Ding","year":"2025","journal-title":"Coron Artery Dis."},{"key":"B15","year":"2023","journal-title":"DecisionLinnc. 1.0."},{"key":"B16","doi-asserted-by":"publisher","first-page":"19563","DOI":"10.1038\/s41598-025-04579-z","article-title":"Machine learning models for predicting severe acute kidney injury in patients with sepsis-induced myocardial injury.","volume":"15","author":"Mi","year":"2025","journal-title":"Sci Rep."},{"key":"B17","doi-asserted-by":"publisher","first-page":"18268","DOI":"10.1038\/s41598-025-02072-1","article-title":"A predictive model for hospital death in cancer patients with acute pulmonary embolism using XGBoost machine learning and SHAP interpretation.","volume":"15","author":"Yuan","year":"2025","journal-title":"Sci Rep."},{"key":"B18","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.eij.2022.10.005","article-title":"Evaluation of Boruta algorithm in DDoS detection.","volume":"24","author":"Farhana","year":"2023","journal-title":"Egyptian Informatics J."},{"key":"B19","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1093\/ndt\/gfae069.1376","article-title":"#322 Are platelet-related parameters prognostic predictors of renal and cardiovascular outcomes in IgA nephropathy?","volume":"39","author":"Kov\u00e1cs","year":"2024","journal-title":"Nephrol Dialysis Transpl."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.21873\/invivo.12909","article-title":"Clinical impact of platelet-to-albumin ratio on esophageal cancer patients who receive curative treatment.","volume":"36","author":"Aoyama","year":"2022","journal-title":"Vivo."},{"key":"B21","doi-asserted-by":"publisher","first-page":"131588","DOI":"10.1016\/j.ijcard.2023.131588","article-title":"Platelet to albumin ratio: a risk factor related to prognosis in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention.","volume":"395","author":"Hao","year":"2024","journal-title":"Int J Cardiol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.thromres.2020.08.019","article-title":"A diagnosis of atrial fibrillation is not a predictor for pulmonary embolism.","volume":"195","author":"Friberg","year":"2020","journal-title":"Thromb Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1161\/CIRCRESAHA.121.318225","article-title":"Inflammation, infection and venous thromboembolism.","volume":"128","author":"Colling","year":"2021","journal-title":"Circ Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"906","DOI":"10.3390\/biomedicines13040906","article-title":"Advanced research in the pathophysiology of venous thromboembolism-acute pulmonary embolism.","volume":"13","author":"Imiela","year":"2025","journal-title":"Biomedicines."},{"key":"B25","doi-asserted-by":"publisher","first-page":"e102","DOI":"10.1111\/ijlh.12867","article-title":"Combined volume of pulmonary embolism and deep venous thrombosis-Association with FV, platelet count, and D-dimer.","volume":"40","author":"Sane","year":"2018","journal-title":"Int J Lab Hematol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.thromres.2017.05.009","article-title":"Platelet hyperactivation, apoptosis and hypercoagulability in patients with acute pulmonary embolism.","volume":"155","author":"Rezania","year":"2017","journal-title":"Thromb Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"ehz747.0353","DOI":"10.1093\/eurheartj\/ehz747.0353","article-title":"P751Low platelets in heart failure: small cells, important impact on all-cause long-term mortality.","volume":"40","author":"Delcea","year":"2019","journal-title":"Eur Heart J."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1182\/blood-2018-08-868067","article-title":"Neutrophils, NETs, and immunothrombosis.","volume":"132","author":"Grover","year":"2018","journal-title":"Blood."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.3390\/ijms17111853","article-title":"Diabetic microvascular disease and pulmonary fibrosis: the contribution of platelets and systemic inflammation.","volume":"17","author":"Jagadapillai","year":"2016","journal-title":"Int J Mol Sci."},{"key":"B30","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1111\/crj.13176","article-title":"The prognostic value of the serum albumin level for long-term prognosis in patients with acute pulmonary embolism.","volume":"14","author":"Tank","year":"2020","journal-title":"Clin Respiratory J."},{"key":"B31","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.ejim.2022.05.004","article-title":"Low serum albumin: a neglected predictor in patients with cardiovascular disease.","volume":"102","author":"Manolis","year":"2022","journal-title":"Eur J Intern Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/j.chest.2022.05.038","article-title":"Anticoagulation for VTE: impact on the risk of major adverse cardiovascular events.","volume":"162","author":"Noumegni","year":"2022","journal-title":"Chest."},{"key":"B33","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1161\/STROKEAHA.118.022620","article-title":"Intravenous thrombolytic therapy remains the basis and mainstay of revascularizing therapy!","volume":"49","author":"Schellinger","year":"2018","journal-title":"Stroke."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1680205\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T05:28:06Z","timestamp":1761283686000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1680205\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,24]]},"references-count":33,"alternative-id":["10.3389\/fmed.2025.1680205"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1680205","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,24]]},"article-number":"1680205"}}